跳至主要内容
临床试验/ITMCTR1900002767
ITMCTR1900002767尚未招募4 期

A randomized, blind, positive-controlled, multicenter study to evaluate the efficacy and safety of Compound Furong effervescent suppository in the treatment of bacterial vaginosis combined with aerobi

Beijing Tsinghua Changgeng Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 55(—)
性别
Female

入选标准

  • 1. Clinical diagnosis of Bacterial Vaginosis combined with aerobic vaginitis;
  • 2. conforms to the syndrome differentiation standard of TCM dampness-heat bet syndrome;
  • 3. Donders score >= 3, <=6;
  • 4. Nugent score >= 7;
  • 5. Aged >= 20, <= 55 years, sexual life history;
  • 6. The patient is willing to participate voluntarily and to sign the informed consent.

排除标准

  • 1. Combined with other vaginitis such as trichomoniasis vaginitis, vulvovaginal candidiasis, or suspected gonorrhea, herpes simplex virus infection caused by reproductive tract infection;
  • 2. Patients with other serious gynecological diseases, such as gynecological malignant tumor and pelvic inflammatory disease;
  • 3. Patients with serious primary diseases such as heart, brain, liver, kidney, blood system and endocrine system, among which ALT or AST over 2-fold of normal value or Scr over normal value.
  • 4. Patients who received any oral or external drug treatment for this disease within one week before enrollment;
  • 5. Pregnancy, breast feeding and the possible pregnancy during study;
  • 6. Those who are known to be allergic to the components of experimental drugs;
  • 7. Persons who have combined neurological or mental disorders and are unable to cooperate, and who suspect or have a history of alcohol or drug abuse;
  • 8. Patient who is participating in other trials or has been participated in other trials in recent 1 months before screen;
  • 9. Not suitable for this study judged by investigater.

研究者

发起方
Beijing Tsinghua Changgeng Hospital

相似试验

尚未招募
不适用
A randomized, controlled, single-blinded, multicenter clinical trial to evaluate the percutaneous radiofrequency treatment of discogenic pain at the ramus communicans versus a sham-operated group
NL-OMON38048Erasmus MC, Universitair Medisch Centrum Rotterdam60
尚未招募
不适用
A randomized, controlled, single-blinded, multicenter clinical trial to evaluate the percutaneous radiofrequency treatment of facet joint pain versus a sham-operated groupFacet jointZygapophyseal joint1002321310009720
NL-OMON38121Erasmus MC, Universitair Medisch Centrum Rotterdam60
尚未招募
4 期
A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapytumor
ITMCTR2000004069West China Hospital, Sichuan University
进行中(未招募)
1 期
A randomized, double-blind, double-dummy, multicenter, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediately after nerve-sparing prostatectomy for improving erectile function - REINVENT (Recovery of Erection: Intervention with Vardenafil Early Nightly Therapy)MedDRA version: 8.1Level: LLTClassification code 10061461Term: Erectile dysfunctionErectile Dysfunction
EUCTR2004-002172-42-GBBayer Healthcare AG
进行中(未招募)
不适用
A randomized, double-blind, double-dummy, multicenter, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediately after nerve-sparing prostatectomy for improving erectile functioErectile Dysfunction
EUCTR2004-002172-42-ITBAYER